NOV 12, 2020 6:00 AM PST

The Enzyme That Keeps Viruses In Stealth Mode

WRITTEN BY: Tara Fernandez

Some viral infections just don’t go away. The hepatitis C virus, for instance, can result in life-long chronic infection if left untreated, leading to potentially life-threatening symptoms such as liver damage. In the case of such infections, why doesn’t the body’s immune system detect and eliminate such viruses?

Researchers at the University of Missouri School of Medicine have found another piece of the puzzle surrounding this question: an enzyme called sphingosine kinase 2, or SphK2, that allows viruses to remain in stealth mode, evading immune clearance. The findings, published in the Journal of Clinical Investigation, point to a promising therapeutic target to treat these persistent viral infections.

Senior author Bumsuk Hahm said, “There is very little research on how the sphingosine kinase 2 (SphK2) enzyme affects the immune responses to viral infections.” 

“We hypothesized that this enzyme suppresses the T cells that fight infections and allows viruses to persist.”

The scientists used a mouse model of lymphocytic choriomeningitis virus infection to test this theory, a common virus affecting rodents. After being administered a pharmaceutical agent to temporarily suppress SphK2, the mice launched a strong immune response that attacked and removed the virus.

“SphK2 is shown to regulate immune cell responses during a viral infection, and inhibition of this enzyme is effective in clearing a persistent viral infection,” said Hahm, who added,  “We believe targeting SphK2 may provide a promising route for developing a drug to elicit protective immunity against viral infections that have a devastating impact on human health.”

Excitingly, inhibiting SphK2 may not only work for getting rid of viruses, but also tumor cells. The study also demonstrated that targeting SphK2 restored the activity of cancer-killing T cells in the immunosuppressive tumor microenvironment.

 

 

Sources: JCI, Technology Networks.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 22, 2020
Immunology
Migraines: Dark Times and (Pharmaceutical) Rays of Hope
OCT 22, 2020
Migraines: Dark Times and (Pharmaceutical) Rays of Hope
Despite being commonly used interchangeably, headaches and migraines are worlds apart. Migraines are by far much more pr ...
NOV 06, 2020
Drug Discovery & Development
New Vaccine Shows Promise for Herpes
NOV 06, 2020
New Vaccine Shows Promise for Herpes
The World Health Organization estimates that over 500 million people have Herpes Simplex Virus Type 2 (HSV-2), a sexuall ...
NOV 16, 2020
Immunology
Australian COVID-19 vaccine is promising and could be released next year
NOV 16, 2020
Australian COVID-19 vaccine is promising and could be released next year
Pharmaceutical companies worldwide are racing to develop a COVID-19 vaccine that will hopefully end this pandemic and he ...
DEC 23, 2020
Immunology
COVID Survivors Stay Immune for at Least a Year
DEC 23, 2020
COVID Survivors Stay Immune for at Least a Year
Once the coronavirus enters the body, the immune system springs into action, producing antibodies that bind to and neutr ...
MAR 02, 2021
Immunology
Another Trick up Tumors' Sleeves Exposed
MAR 02, 2021
Another Trick up Tumors' Sleeves Exposed
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...
MAR 04, 2021
Immunology
Climate Change Tightens Its Grip on Hay Fever Sufferers
MAR 04, 2021
Climate Change Tightens Its Grip on Hay Fever Sufferers
There’s bad news for pollen allergy sufferers: New research has shown that climate change is making hay fever seas ...
Loading Comments...